Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Cell Transplant ; 29: 963689720950641, 2020.
Article in English | MEDLINE | ID: mdl-32806929

ABSTRACT

Stem cell transplantation remains the curative option for many patients with hematological malignancies. The long-term effects of these treatments on the patients and their immune systems have been extensively investigated, but there remains a paucity of data regarding autoimmune manifestations post-transplant, although these effects are well recognized.Herein we present the clinical picture and therapeutic approach in three patients (cases 1-3), with varied presentations of autoimmune disease post-transplant. Case 1 exhibited autoimmune hemolytic anemia and other autoimmune manifestations (serositis, thyroiditis), that were probably linked to graft versus relapsed leukemia effect. Cases 2 and 3 had pure red white cell aplasia and pure red cell aplasia, respectively, which were associated with hyperglobulinemia and a clonal T cell expansion.


Subject(s)
Alemtuzumab/adverse effects , Autoimmune Diseases/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Adult , Female , Humans , Male , Middle Aged , Transplantation, Homologous
SELECTION OF CITATIONS
SEARCH DETAIL